Zhao Yan New Drug: A subsidiary will invest 10 million yuan to participate in the establishment of a 128 million yuan investment fund.

Zhao Yan Pharmaceutical announced that its wholly-owned subsidiary, Beijing Zhao Yan Management Technology Co., Ltd., recently signed a partnership agreement with Yifeng Mingyuan, Yifeng Capital, and others to participate in the establishment of the Shenzhen Yifeng Mingyuan Seed Entrepreneurship Investment Partnership. The fund aims to raise 128 million yuan, with a duration of 10 years, and will be invested in strategic emerging industries and future industrial related fields in Shenzhen. Zhao Yan Pharmaceutical's subsidiary subscribed 10 million yuan, accounting for 7.84%. The fund still needs to go through filing procedures, and there are uncertainties in its implementation. The company will closely monitor and disclose any updates in a timely manner.